Loading...

Edwards Lifesciences Corporation

EW•NYSE
Healthcare
Medical - Devices
$84.15
$4.43(5.56%)
U.S. Market opens in 30h 28m

Edwards Lifesciences Corporation (EW) Stock Overview

Explore Edwards Lifesciences Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap48.6B
P/E Ratio45.42
EPS (TTM)$1.81
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$86.04
3 Months$94.32
1 Year Target$80.09

EW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Edwards Lifesciences Corporation (EW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $80.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 45.42 and a market capitalization of 48.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.59%
5-Day Change
6.83%
1-Month Change
3.04%
3-Month Change
0.62%
6-Month Change
10.61%
Year-to-Date (YTD) Change
-1.26%
1-Year Change
12.04%
3-Year Change
-5.20%
5-Year Change
-12.35%
All-Time (Max) Change
6021.82%

Contact Information

https://www.edwards.com
949 250 2500
One Edwards Way, Irvine, CA, 92614

Company Facts

15,800 Employees
IPO DateMar 27, 2000
CountryUS
Actively Trading

Frequently Asked Questions